On Monday, Wave Life Sciences Ltd (NASDAQ: WVE) was 12.45% jump from the session before settling in for the closing price of $15.98. A 52-week range for WVE has been $5.28 – $21.73.
Annual sales at Healthcare sector company grew by 34.27% over the past five years. When this article was written, the company’s average yearly earnings per share was at -69.95%. With a float of $147.79 million, this company’s outstanding shares have now reached $160.29 million.
Wave Life Sciences Ltd (WVE) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Wave Life Sciences Ltd stocks. The insider ownership of Wave Life Sciences Ltd is 19.24%, while institutional ownership is 75.29%. The most recent insider transaction that took place on Dec 11 ’25, was worth 27,930,000. In this transaction 10% Owner of this company bought 1,470,000 shares at a rate of $19.00, taking the stock ownership to the 18,245,691 shares. Before that another transaction happened on Dec 08 ’25, when Company’s Director sold 42,000 for $15.00, making the entire transaction worth $630,000. This insider now owns 12,700 shares in total.
Wave Life Sciences Ltd (WVE) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 0.27 earnings per share (EPS) during the time that was better than consensus figure (set at -0.22) by 0.5. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -69.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -19.25% during the next five years compared to 34.27% growth over the previous five years of trading.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
You can see what Wave Life Sciences Ltd (WVE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 30.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.75, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -1.24 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Wave Life Sciences Ltd (NASDAQ: WVE) saw its 5-day average volume 4.56 million, a positive change from its year-to-date volume of 2.71 million. As of the previous 9 days, the stock’s Stochastic %D was 30.85%.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 75.30%, which indicates a significant increase from 74.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.96 in the past 14 days, which was higher than the 0.70 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.72, while its 200-day Moving Average is $8.14. Nevertheless, the first resistance level for the watch stands at $18.83 in the near term. At $19.70, the stock is likely to face the second major resistance level. The third major resistance level sits at $21.21. If the price goes on to break the first support level at $16.45, it is likely to go to the next support level at $14.94. Assuming the price breaks the second support level, the third support level stands at $14.07.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
There are 167,182K outstanding shares of the company, which has a market capitalization of 3.29 billion. As of now, sales total 108,300 K while income totals -97,010 K. Its latest quarter income was 7,610 K while its last quarter net income were -53,850 K.
